| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 09/03/2009 | WO2009043031A3 Microbubbles and methods for oxygen delivery |
| 09/03/2009 | WO2009040018A3 Use of a peptide as a therapeutic agent |
| 09/03/2009 | WO2009040017A3 Use of a peptide as a therapeutic agent |
| 09/03/2009 | WO2009039993A3 Use of melanocyte-stimulating hormone release-inhibiting factor as a therapeutic agent in the treatment of pseudomonas aeruginosa infection |
| 09/03/2009 | WO2009039992A3 Use of band 3 protein (824-829) and/or melanocyte-stimulating hormone release-inhibiting factor as a therapeutic agent in the treatment of pseudomonas aeruginosa infection |
| 09/03/2009 | WO2009039988A3 Use of a fibrinogen receptor antagonist and/or follicular gonadotropin releasing peptide as a therapeutic agent in the treatment of streptococcus pneumonia infection |
| 09/03/2009 | WO2009033805A3 Use of somatostatin-14 as a therapeutic agent |
| 09/03/2009 | WO2009033802A3 Antide as a therapeutic agent |
| 09/03/2009 | WO2009033801A3 Syndyphalin alone or in combination with antide as a therapeutic agent |
| 09/03/2009 | WO2009033755A3 Use of l-carnosine as a therapeutic agent |
| 09/03/2009 | WO2009033741A3 Use of lvv-hemorphin-6 and optionally af12198 as therapeutic agent(s) |
| 09/03/2009 | WO2009033737A3 Use of gluten exorphin c : as a therapeutic agent |
| 09/03/2009 | WO2009033731A3 Use of a laminin peptide as a therapeutic agent |
| 09/03/2009 | WO2009033723A3 Use of aip2 as a therapeutic agent |
| 09/03/2009 | WO2009033714A3 Use of a peptide as a therapeutic agent |
| 09/03/2009 | WO2009033692A3 Use of the peptides fibrinopeptide a and pyx-i as a therapeutic agents |
| 09/03/2009 | WO2009033665A3 Use of a rgd-peptide and/or parathyroid hormone (1-34 ) as anti-hiv agent |
| 09/03/2009 | WO2009033656A3 Use of follicular gonadotropin releasing peptide as a therapeutic agent in the treatment of streptococcus pneumoniae infection |
| 09/03/2009 | WO2009001322A3 Caspase inhibitors for treating pathologies resulting from ischemia |
| 09/03/2009 | US20090221821 Adenosine receptor antagonists and methods of making and using the same |
| 09/03/2009 | US20090221712 Mandelic hydrazides |
| 09/03/2009 | US20090221710 Acyclic Sulfamide Derivatives |
| 09/03/2009 | US20090221701 Use of fibrates for the preparation of a medicament useful in the treatment of congestive heart failure |
| 09/03/2009 | US20090221686 Modulation of the Transcription of Pro-Inflammatory Gene Products |
| 09/03/2009 | US20090221657 Compounds, Compositions Containing Them, Preparation Thereof and Uses Thereof I |
| 09/03/2009 | US20090221656 Drug Combinations |
| 09/03/2009 | US20090221649 Use of substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines for the treatment of reperfusion injury and reperfusion damage |
| 09/03/2009 | US20090221632 Bicyclo-Pyrazoles and Pharmaceutical Compositions Comprising Them |
| 09/03/2009 | US20090221602 Processes for preparing substituted pyrimidines |
| 09/03/2009 | US20090221564 Heterocyclic Compounds and Their Use in the Treatment of Cardiovascular Disease |
| 09/03/2009 | US20090221549 Antihypertensive therapy |
| 09/03/2009 | US20090221546 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade |
| 09/03/2009 | US20090221543 New corticosteroids |
| 09/03/2009 | US20090221540 Method of Treating An Acute Vascular Disorder |
| 09/03/2009 | US20090221519 Combinations of receptor tyrosine kinase inhibitor with an a1-acidic glycoprotein binding compound |
| 09/03/2009 | US20090221504 Dose of an angiogenic factor and method of administering to improve myocardial blood flow |
| 09/03/2009 | US20090221496 novel antithrombotic agent |
| 09/03/2009 | US20090220626 Grape seed extract and its constituents for use as cyp2a6 inhibitors |
| 09/03/2009 | US20090220606 Treatment and prevention of abnormal cellular proliferation |
| 09/03/2009 | US20090220603 Use of rhamnolipids in wound healing, treating burn shock, atherosclerosis, organ transplants, depression, schizophrenia and cosmetics |
| 09/03/2009 | US20090220586 Proteomimetic compounds as inhibitors of the interaction of nuclear receptor with coactivator peptides |
| 09/03/2009 | US20090220565 Method for producing autonomously contracting cardiac muscle cells from adult stem cells, in particular human adult stem cells |
| 09/03/2009 | US20090220507 Inhibition of extracellular signal-regulated kinase 1/2 as a treatment for cardiac hypertrophy and heart failure |
| 09/03/2009 | US20090220500 Agents for treating cardiopathy |
| 09/03/2009 | DE19521720B4 Insulinanalogonformulierungen Insulin analog formulations |
| 09/03/2009 | CA2716852A1 High-molecular-weight adiponectin measurement method |
| 09/03/2009 | CA2716835A1 Methods of treating cardiovascular disorders associated with atherosclerosis |
| 09/03/2009 | CA2716400A1 Method for increasing the activity of the immune system of a mammal at risk of inflammatory diseases |
| 09/03/2009 | CA2716397A1 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the .beta.2 adrenergic receptor |
| 09/03/2009 | CA2715726A1 Novel crystalline forms |
| 09/03/2009 | CA2712695A1 New angiotensin ii receptor blocker derivatives |
| 09/03/2009 | CA2712689A1 Angiotensin ii receptor antagonists |
| 09/03/2009 | CA2710962A1 Derivatives of 2-heteroaroyl-imidazol[1,2-a]pyridine, preparation thereef and therapeutic application thereof |
| 09/03/2009 | CA2710947A1 Derivatives of 6-heterocyclic-imidazo[1,2-a]pyrroine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 09/03/2009 | CA2710794A1 Derivatives of n-heterocyclic-6-heterocyclic-imidazo[l,2-.alpha.]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 09/03/2009 | CA2709863A1 Azetidine derivatives, their preparation and their application in therapy |
| 09/02/2009 | EP2096167A1 Aptamer against midkine and use thereof |
| 09/02/2009 | EP2096105A1 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the b2 adrenergic receptor |
| 09/02/2009 | EP2095824A1 A method for restoring BMP-receptor signaling in a cell |
| 09/02/2009 | EP2095819A1 N-benzyl imidazole derivatives and their use as aldosterone synthase inhibitors |
| 09/02/2009 | EP2095127A1 Methods for screening and treatment involving the genes gypc, agpat3, agl, pvrl2, hmgb 3, hsdl2 and/or ldb2 |
| 09/02/2009 | EP2094720A1 Selective inhibitors of neurotensin degrading enzymes |
| 09/02/2009 | EP2094669A2 1-substituted imidazole derivatives and their use as aldosterone synthase inhibitors |
| 09/02/2009 | EP2094668A2 4-imidazolines as taar's ligands |
| 09/02/2009 | EP2094289A1 Conjoint therapy for treating fibrotic diseases |
| 09/02/2009 | EP2094271A2 Drug combinations for treating airway diseases |
| 09/02/2009 | EP2094259A1 Renin inhibitors for the prevention and treatment of hypertension in obese patients |
| 09/02/2009 | EP2094258A1 Pharmaceutical composition using aliskiren and avosentan |
| 09/02/2009 | EP2094257A1 Methods for improving bioavailability of a renin inhibitor |
| 09/02/2009 | EP2094255A1 Modulators of beta-2-adrenergic receptor for treating conditions characterized by disorganized vasculature |
| 09/02/2009 | EP1496890B1 Substituted beta-aminoalcohols used as medicaments |
| 09/02/2009 | EP1470137B1 Edg receptor agonists |
| 09/02/2009 | EP1458392B1 Acridones as inhibitors of impdh enzyme |
| 09/02/2009 | EP1457498B9 Novel peptide having angiotensin convertase inhibitory effect |
| 09/02/2009 | EP1423115B9 Antiangiogenic activity of nitrogen substituted thalidomide analogs |
| 09/02/2009 | EP1392349B1 Use of angiotensinogen and its derivatives for manufacturing anti-angiogenesis pharmaceutical compositions |
| 09/02/2009 | EP1317479B1 Methods and compositions for diseases associated with amyloidosis |
| 09/02/2009 | EP1282617B1 Hydantoin derivatives with affinity for somatostatin receptors |
| 09/02/2009 | EP1276483B1 Compositions and methods for treating amyloidosis using sulphonate derivatives |
| 09/02/2009 | EP1262546B1 Novel scavenger receptors |
| 09/02/2009 | CN101522222A Identification of a micro-RNA that activates expression of beta-myosin heavy chain |
| 09/02/2009 | CN101519663A Recombinant CREG protein and application thereof |
| 09/02/2009 | CN101519444A Method for preparing Nesiritide |
| 09/02/2009 | CN101519427A Peptide derivative with endothelin receptor antagonizing activity, drug composition and application thereof |
| 09/02/2009 | CN101519404A 15-cyclothiaketone derivative, preparation method and application thereof |
| 09/02/2009 | CN101519393A Novel method for preparing Scopoletin |
| 09/02/2009 | CN101519386A Large conductance calcium-activated K channel opener |
| 09/02/2009 | CN101519385A Small molecule compound being capable of promoting proliferation of stem cells and function thereof |
| 09/02/2009 | CN101519345A Trans-3,5-dihydroxyl-4'-bromo butoxyl toluylene as well as preparation and application thereof |
| 09/02/2009 | CN101518650A Combination of a DPP IV inhibitor and a cardiovascular compound |
| 09/02/2009 | CN101518648A Soluble receptor BR43x2 and methods of using |
| 09/02/2009 | CN101518638A Pearl pill and method for preparing same |
| 09/02/2009 | CN101518618A Traditional Chinese medicine preparation for treating myocardial infarction |
| 09/02/2009 | CN101518617A Pharmaceutical composition for improving safety of Shenmai injection and method for preparing same |
| 09/02/2009 | CN101518612A Medical composition applied to preventing and treating high blood pressure and preparation method thereof |
| 09/02/2009 | CN101518605A Pure natural medicament for treating cardiovascular and cerebrovascular diseases |
| 09/02/2009 | CN101518598A Tea oral tablet and preparation method thereof |
| 09/02/2009 | CN101518583A Chinese patent medicament for external application with functions of warming meridians and activating collaterals |
| 09/02/2009 | CN101518579A Pressure stabilizing deoppilant and preparation process |
| 09/02/2009 | CN101518576A Traditional Chinese preparation used for treating cerebrovascular disease |